sk&f-38393 has been researched along with Osteogenic Sarcoma in 2 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J | 2 |
| Gao, F | 2 |
| Zhang, C | 1 |
| Li, H | 1 |
2 other studies available for sk&f-38393 and Osteogenic Sarcoma
| Article | Year |
|---|---|
Dopamine D1 receptors induce apoptosis of osteosarcoma cells via changes of MAPK pathway.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Apoptosis; Cell Line, Tumor; Cell Surviv | 2017 |
The effect and mechanism of dopamine D1 receptors on the proliferation of osteosarcoma cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Benzazepines; Bone Neoplasms; Cell Line, | 2017 |